Mental health Compass Pathways Soars: Analysts Eye 223% Upside After Historic Psilocybin Breakthrough March 08, 2026
Mental health Psilocybin Therapy Reaches Final Stage: FDA Review Could Deliver Breakthrough in 2026 March 07, 2026
Mental health COMP360 Psilocybin Breakthrough: Phase 3 Success Paves Way for FDA Approval March 07, 2026
Mental health FDA Approves Revolutionary XCSITE 'Brainwave-Tuning' Device for Depression March 01, 2026
Mental health Breaking: FDA Clears Revolutionary XCSITE 'Brain-Tuning' Wearable for Rapid Depression Relief February 28, 2026
Mental health FDA Approves Bysanti: Breakthrough Schizophrenia & Bipolar I Treatment February 27, 2026
